Effects of Cimetidine and Dolutegravir on the Endogenous Drug-Drug Interaction Biomarkers for Organic Cation Transporter 2 and Multidrug and Toxin Extrusion Protein 1 in Healthy Volunteers.
Saved in:
| Title: | Effects of Cimetidine and Dolutegravir on the Endogenous Drug-Drug Interaction Biomarkers for Organic Cation Transporter 2 and Multidrug and Toxin Extrusion Protein 1 in Healthy Volunteers. |
|---|---|
| Authors: | Koishikawa T; Laboratory of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo City, Japan., Fujiwara K; Laboratory of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo City, Japan., Taskar K; Drug Metabolism and Pharmacokinetic, GSK, Stevenage, UK., Zamek-Gliszczynski MJ; Drug Metabolism and Pharmacokinetic, GSK, Collegeville, Pennsylvania, USA., Yoshida K; Clinical Pharmacology, Genentech, Inc., South San Francisco, California, USA., Chu X; Department of Pharmacokinetics, Dynamics, Metabolism, and Bioanalytics, Merck & Co., Inc., Rahway, New Jersey, USA., Hirabayashi H; Center of Excellence for Drug Metabolism, Pharmacokinetics and Modeling, Preclinical and Translational Sciences, Research, Takeda Pharmaceutical Company Limited, Kanagawa, Japan., Mao J; Drug Metabolism and Pharmacokinetics, Genentech, Inc., South San Francisco, California, USA., Rockich K; Drug Metabolism, Pharmacokinetics and Clinical Pharmacology, Incyte Research Institute, Wilmington, Delaware, USA., Takashima T; Laboratory for Safety Assessment & ADME, Pharmaceuticals Research Center, Asahi Kasei Pharma Corporation, Shizuoka, Japan., Yamaura Y; Pharmacokinetic Research Laboratories, Ono Pharmaceutical Co., Ltd., Osaka, Japan., Lai Y; Drug Metabolism Department, Gilead Sciences Inc., Foster City, California, USA., Tomoda Y; Laboratory of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo City, Japan., Kito T; Laboratory of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo City, Japan., Maeda K; Laboratory of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo City, Japan.; Faculty of Pharmaceutical Sciences, Kitasato University, Tokyo, Japan., Furihata K; P-One Clinic, Keikokai Medical Corp, Tokyo, Japan., Sugiyama Y; Sugiyama Laboratory, RIKEN Baton Zone Program, RIKEN Cluster for Science, Technology and Innovation Hub, RIKEN, Yokohama, Kanagawa, Japan., Kusuhara H; Laboratory of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo City, Japan. |
| Source: | Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2025 Feb; Vol. 117 (2), pp. 523-533. Date of Electronic Publication: 2024 Nov 05. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39497599 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Effects of Cimetidine and Dolutegravir on the Endogenous Drug-Drug Interaction Biomarkers for Organic Cation Transporter 2 and Multidrug and Toxin Extrusion Protein 1 in Healthy Volunteers. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Koishikawa+T%22">Koishikawa T</searchLink>; Laboratory of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo City, Japan.<br /><searchLink fieldCode="AU" term="%22Fujiwara+K%22">Fujiwara K</searchLink>; Laboratory of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo City, Japan.<br /><searchLink fieldCode="AU" term="%22Taskar+K%22">Taskar K</searchLink>; Drug Metabolism and Pharmacokinetic, GSK, Stevenage, UK.<br /><searchLink fieldCode="AU" term="%22Zamek-Gliszczynski+MJ%22">Zamek-Gliszczynski MJ</searchLink>; Drug Metabolism and Pharmacokinetic, GSK, Collegeville, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Yoshida+K%22">Yoshida K</searchLink>; Clinical Pharmacology, Genentech, Inc., South San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Chu+X%22">Chu X</searchLink>; Department of Pharmacokinetics, Dynamics, Metabolism, and Bioanalytics, Merck & Co., Inc., Rahway, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Hirabayashi+H%22">Hirabayashi H</searchLink>; Center of Excellence for Drug Metabolism, Pharmacokinetics and Modeling, Preclinical and Translational Sciences, Research, Takeda Pharmaceutical Company Limited, Kanagawa, Japan.<br /><searchLink fieldCode="AU" term="%22Mao+J%22">Mao J</searchLink>; Drug Metabolism and Pharmacokinetics, Genentech, Inc., South San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Rockich+K%22">Rockich K</searchLink>; Drug Metabolism, Pharmacokinetics and Clinical Pharmacology, Incyte Research Institute, Wilmington, Delaware, USA.<br /><searchLink fieldCode="AU" term="%22Takashima+T%22">Takashima T</searchLink>; Laboratory for Safety Assessment & ADME, Pharmaceuticals Research Center, Asahi Kasei Pharma Corporation, Shizuoka, Japan.<br /><searchLink fieldCode="AU" term="%22Yamaura+Y%22">Yamaura Y</searchLink>; Pharmacokinetic Research Laboratories, Ono Pharmaceutical Co., Ltd., Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Lai+Y%22">Lai Y</searchLink>; Drug Metabolism Department, Gilead Sciences Inc., Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Tomoda+Y%22">Tomoda Y</searchLink>; Laboratory of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo City, Japan.<br /><searchLink fieldCode="AU" term="%22Kito+T%22">Kito T</searchLink>; Laboratory of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo City, Japan.<br /><searchLink fieldCode="AU" term="%22Maeda+K%22">Maeda K</searchLink>; Laboratory of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo City, Japan.; Faculty of Pharmaceutical Sciences, Kitasato University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Furihata+K%22">Furihata K</searchLink>; P-One Clinic, Keikokai Medical Corp, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Sugiyama+Y%22">Sugiyama Y</searchLink>; Sugiyama Laboratory, RIKEN Baton Zone Program, RIKEN Cluster for Science, Technology and Innovation Hub, RIKEN, Yokohama, Kanagawa, Japan.<br /><searchLink fieldCode="AU" term="%22Kusuhara+H%22">Kusuhara H</searchLink>; Laboratory of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo City, Japan. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220372741%22">Clinical pharmacology and therapeutics</searchLink> [Clin Pharmacol Ther] 2025 Feb; Vol. 117 (2), pp. 523-533. <i>Date of Electronic Publication: </i>2024 Nov 05. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0372741 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-6535 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200099236%22">00099236 </searchLink><i>NLM ISO Abbreviation: </i>Clin Pharmacol Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39497599 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/cpt.3482 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 523 Titles: – TitleFull: Effects of Cimetidine and Dolutegravir on the Endogenous Drug-Drug Interaction Biomarkers for Organic Cation Transporter 2 and Multidrug and Toxin Extrusion Protein 1 in Healthy Volunteers. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Koishikawa T – PersonEntity: Name: NameFull: Fujiwara K – PersonEntity: Name: NameFull: Taskar K – PersonEntity: Name: NameFull: Zamek-Gliszczynski MJ – PersonEntity: Name: NameFull: Yoshida K – PersonEntity: Name: NameFull: Chu X – PersonEntity: Name: NameFull: Hirabayashi H – PersonEntity: Name: NameFull: Mao J – PersonEntity: Name: NameFull: Rockich K – PersonEntity: Name: NameFull: Takashima T – PersonEntity: Name: NameFull: Yamaura Y – PersonEntity: Name: NameFull: Lai Y – PersonEntity: Name: NameFull: Tomoda Y – PersonEntity: Name: NameFull: Kito T – PersonEntity: Name: NameFull: Maeda K – PersonEntity: Name: NameFull: Furihata K – PersonEntity: Name: NameFull: Sugiyama Y – PersonEntity: Name: NameFull: Kusuhara H IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2025 Feb Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1532-6535 Numbering: – Type: volume Value: 117 – Type: issue Value: 2 Titles: – TitleFull: Clinical pharmacology and therapeutics Type: main |
| ResultId | 1 |